Reliant AI provides GenAI-powered data analytics software for the biopharma industry. Founded by natural language processing and reinforcement learning experts, the company is headquartered in Montreal, Canada, with an additional office in Berlin, Germany. Its primary offering is Reliant Tabular, an AI workbench designed to assist life science analysts in finding scientific evidence for decision-making through automated systematic reviews, asset scans, and comprehensive analyses.
Reliant Tabular utilizes specialized LLMs to process and analyze complex data in the domain of life sciences. The platform allows users to query vast amounts of scientific literature and clinical trial data using natural language inputs. It indexes over 38 million scientific publications, conference abstracts, and clinical trials, enabling rapid data retrieval and analysis. Reliant Tabular offers features such as automated competitor reports, systematic literature reviews, and market trend forecasting. The company claims that its platform can perform asset scans 4.8x faster than manual methods and makes 10x fewer errors compared to average analysts or general-purpose AI software.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.